reference/15907773

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15907773

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	37
issn	1064-7449 1098-0997
issueIdentifier	1
pageRange	27-37
publicationName	Infectious Diseases in Obstetrics and Gynecology
startingPage	27
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f3adb2487eb1d8d5b24b68a3e156f5fb
bibliographicCitation	Roy S, Higareda I, Angel-Muller E, Ismail M, Hague C, Adeyi B, Woods GL, Teppler H; Protocol 023 Study Group. Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study. Infect Dis Obstet Gynecol. 2003;11(1):27–37. PMID: 12839630; PMCID: PMC1852268.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08fe2ecb1f6a53ded1621f5664c1bda9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2fc996d28ff88696d371c1c030c0f0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_949dc124079fbebdf03d2cb4df3051fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65faf2414d11989fb656d9beaafdfef5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7342772b327095c99cdfa0866a01ff53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9737cc4a2e53d316117ee624ca0394c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73946f90c55aeaf830b83b3b62fde265 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7111e79505c28f0c80b8b3ba9eed8148
date	2003
identifier	https://doi.org/10.1155/s1064744903000048 https://pubmed.ncbi.nlm.nih.gov/PMC1852268 https://pubmed.ncbi.nlm.nih.gov/12839630
isPartOf	https://portal.issn.org/resource/ISSN/1064-7449 https://portal.issn.org/resource/ISSN/1098-0997 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21029
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Ertapenem Once a Day Versus Piperacillin–Tazobactam Every 6 Hours for Treatment of Acute Pelvic Infections: A Prospective, Multicenter, Randomized, Double-Blind Study
discusses	http://id.nlm.nih.gov/mesh/M0448397 http://id.nlm.nih.gov/mesh/M0012144 http://id.nlm.nih.gov/mesh/M0012143 http://id.nlm.nih.gov/mesh/M0127405 http://id.nlm.nih.gov/mesh/M0016125 http://id.nlm.nih.gov/mesh/M0016883 http://id.nlm.nih.gov/mesh/M0414190
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D034161Q000188 http://id.nlm.nih.gov/mesh/D007769 http://id.nlm.nih.gov/mesh/D010397Q000031 http://id.nlm.nih.gov/mesh/D000900Q000008 http://id.nlm.nih.gov/mesh/D010397Q000008 http://id.nlm.nih.gov/mesh/D010878Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D000077727 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D011336 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D034161Q000382 http://id.nlm.nih.gov/mesh/D000208 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D047090 http://id.nlm.nih.gov/mesh/D016001 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000078142 http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9018 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23724843 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150610 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10755 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135951164 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129105226 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135841765 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248087834

Total number of triples: 73.